Overview: Chlamydia Serology TestIntroduction: The Chlamydia Serology Test detects antibodies to Chlamydia, indicating infection causing pelvic pain or eye infections. Following 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in serology for patients with suspected Chlamydia infection.
Other Names: Chlamydia Antibody Assay, Chlamydia Infection Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Chlamydia serology testing began in the 1980s with infection research. Immunoassays emerged in the 1990s, and by the 2000s, high-sensitivity assays improved detection accuracy.
Purpose: Diagnoses Chlamydia infection, guides treatment, and monitors antibody levels in patients with pelvic pain or eye infections.
Test Parameters: 1. Chlamydia Antibodies
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report symptoms like pelvic pain or conjunctivitis, and list recent antibiotic use.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document pelvic pain, eye infections, or sexual history. Include current medications, especially antibiotics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antibiotic therapy.
Procedural Considerations: Uses an immunoassay to measure Chlamydia antibodies. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Recent antibiotics may suppress antibody levels. Hemolysis or improper storage can degrade samples.
Clinical Significance: Positive results confirm past or current Chlamydia infection, prompting antibiotic therapy. Negative results may require PCR testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation. A gynecologist or ophthalmologist referral is advised for specific symptoms.
Additional Supporting Tests: Chlamydia PCR, IgG/IgM tests, or culture to confirm active infection.
Test Limitations: False negatives may occur with early infection. Results require clinical correlation with history.
References: IDSA Chlamydia Guidelines, 2023; Clinical Infectious Diseases, Workowski KA, 2022.
